Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Post

Showing results (501-510 of 513) with videos related to

Pageof 52
Sort By:
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
Orphanet Journal of Rare Diseases|July 1, 2020
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)Omer F Eker, Edoardo Boccardi, Ulrich Sure, et al.
Chest|May 7, 2026
Comparison of Hemodynamic Responses to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension in Japan and the Netherlands: a multicenter studySatoshi Higuchi, Konstantinos Mantzios, Takatoyo Kiko, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 3, 2025
ENDOCOR: a nationwide consortium of endocarditis teams-initiating a registry for infective endocarditis within the Netherlands Heart RegistrationAnnelot J L Peijster, Floris J Heinen, Sabrine Douiyeb, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 29, 2019
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trialJ J Brugts, J F Veenis, S P Radhoe, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Plos One|June 14, 2019
Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosisFarrel J Buchinsky, William L Valentino, Nicole Ruszkay, et al.
Circulation|March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart FailureBarry A Borlaug, John Blair, Martin W Bergmann, et al.
Journal of the American Heart Association|September 5, 2022
Clinical Characteristics of Patients Undergoing Right Heart Catheterizations in Community HospitalsSamara M A Jansen, Anna E Huis In 't Veld, Peter Hans C G Tolen, et al.
European Heart Journal|May 11, 2024
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trialPascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, et al.
Pageof 52

Showing results (501-510 of 513) with videos related to

Sort By:
Pageof 52
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
Orphanet Journal of Rare Diseases|July 1, 2020
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)Omer F Eker, Edoardo Boccardi, Ulrich Sure, et al.
Chest|May 7, 2026
Comparison of Hemodynamic Responses to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension in Japan and the Netherlands: a multicenter studySatoshi Higuchi, Konstantinos Mantzios, Takatoyo Kiko, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 3, 2025
ENDOCOR: a nationwide consortium of endocarditis teams-initiating a registry for infective endocarditis within the Netherlands Heart RegistrationAnnelot J L Peijster, Floris J Heinen, Sabrine Douiyeb, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 29, 2019
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trialJ J Brugts, J F Veenis, S P Radhoe, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Plos One|June 14, 2019
Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosisFarrel J Buchinsky, William L Valentino, Nicole Ruszkay, et al.
Circulation|March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart FailureBarry A Borlaug, John Blair, Martin W Bergmann, et al.
Journal of the American Heart Association|September 5, 2022
Clinical Characteristics of Patients Undergoing Right Heart Catheterizations in Community HospitalsSamara M A Jansen, Anna E Huis In 't Veld, Peter Hans C G Tolen, et al.
European Heart Journal|May 11, 2024
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trialPascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, et al.
Pageof 52